ClinicalTrials.Veeva

Menu

A Contribution to the Analysis of the Phenotypic Heterogeneity in Crack/Cocaine Addiction : a Case Control Study (CRACK-ANT)

U

University Hospital Center of Martinique

Status

Unknown

Conditions

Dependence, Cocaine

Treatments

Genetic: Collect 10 ml of Saliva for DNA extraction

Study type

Interventional

Funder types

Other

Identifiers

NCT01025219
09/B/01

Details and patient eligibility

About

The purpose of this study is to assess the phenotypic candidates symptoms, in patients with crack/cocaine addiction, in terms of clinical comorbidities, dimensions of personality, and neuropsychological evaluations apt to be associated with genetic and genotypic characterisations, notably on the polymorphisms of the genes coding or regulating dopaminergic, norepinephrine and serotoninergic systems.

Full description

Genetic studies show an association between drug addiction and the dopaminergic system and its modulators. Nonetheless, results are contradictory, partially due to the heterogeneity of the phenotype addiction. Placed on the trafficking route of cocaine, and homogeneously populated, Martinique is of particular interest for the study of the vulnerability of the crack/cocaine addiction. In a precedent study, supported by a grant MILDT / INSERM 2000, on 155 men dependent to crack/cocaine and characterised with three clinical dimensions -sensation seeking, impulsivity and childhood ADHD- we found an association between each dimension and polymorphisms of DRD2 and DRD4 genes.

Enrollment

600 estimated patients

Sex

Male

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosis of cocaine abuse/dependence according to DSM-IV-TR criteria
  • Come from French West Indies (3 grandparents are African-Caribbean)
  • Sign a written informed consent

Exclusion criteria

  • Minor
  • Men with no cocaine abuse/dependence according to DSM-IV-TR criteria

For the control:

Inclusion Criteria:

  • Platelets donor
  • No substance abuse/dependence according to DSM-IV-TR criteria
  • Come from French West Indies (3 grandparents are African-Caribbean)
  • Sign a written informed consent

Exclusion Criteria:

  • Minor
  • Men refusing a genetic study

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Jérôme LACOSTE, MD; Jocelyne CRASPAG, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems